- Previous Close
0.089 - Open
0.090 - Bid 0.082 x --
- Ask 0.090 x --
- Day's Range
0.082 - 0.090 - 52 Week Range
0.066 - 0.152 - Volume
48,000 - Avg. Volume
217,079 - Market Cap (intraday)
81.404M - Beta (5Y Monthly) 0.94
- PE Ratio (TTM)
-- - EPS (TTM)
-0.010 - Earnings Date Nov 25, 2024 - Nov 29, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date Aug 31, 2017
- 1y Target Est
--
Modern Healthcare Technology Holdings Limited, an investment holding company, provides beauty and wellness services in Hong Kong, the People's Republic of China, Singapore, and Australia. The company operates in two segments, Beauty and Wellness Services, and Skincare and Wellness Products. It offers beauty and facial services; aesthetics services, such as skincare treatment, professional consultation, skin care and anti-ageing, and referral services on plastic reconstruction; slimming services, including weight management programs; spa and massage services including resplendent bathroom furnishings and a hydrotherapeutic pool, as well as foot spa, foot treatment, and foot massage services; haircare and removal; make-up; joint and intimate care; and body check and genetic test services. The company also sells skincare and wellness products under the be, FERRECARE, p.e.n, Y.U.E., Advanced Natural, Malu Wilz, Byotea, Care Plus, Cellnoc, Mu-lan Spa, Cellnoc, Veribel, Castille, Dr Plus, Eclat du teint, and Natural Care brand names. In addition, it provides sub-franchising services in relation to beautification and gymnastic services; beauty and wellness treatment training program; beauty consultancy services; fund management services; advertising services; maid agency services; licensing services; and management services, as well as food and beverage services. The company was formerly known as Modern Beauty Salon Holdings Limited and changed its name to Modern Healthcare Technology Holdings Limited. The company was incorporated in 2005 and is headquartered in Kowloon Bay, Hong Kong.
www.modernhealthcaretech.com844
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: 0919.HK
View MorePerformance Overview: 0919.HK
Trailing total returns as of 11/22/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 0919.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 0919.HK
View MoreValuation Measures
Market Cap
81.40M
Enterprise Value
-5.68M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.18
Price/Book (mrq)
0.43
Enterprise Value/Revenue
0.01
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-2.09%
Return on Assets (ttm)
1.47%
Return on Equity (ttm)
-4.33%
Revenue (ttm)
457.43M
Net Income Avi to Common (ttm)
-9.57M
Diluted EPS (ttm)
-0.010
Balance Sheet and Cash Flow
Total Cash (mrq)
193.66M
Total Debt/Equity (mrq)
54.83%
Levered Free Cash Flow (ttm)
89.77M